SignPath Pharma, Inc. - FORM 10-K - EX-32.1 - CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. - March 30, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - SignPath Pharma, Inc.Financial_Report.xls
10-K - SIGNPATH PHARMA, INC. 10K 2011-12-31 - SignPath Pharma, Inc.signpath10k.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - SignPath Pharma, Inc.signpath10kexh311.htm
Exhibit 32.1
 

 
CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Lawrence Helson, Chief Executive Officer and Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
 
1.
The Annual Report on Form 10-K for the year ended December 31, 2010 (the "Report") fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of SignPath Pharma Inc.
 
Dated March 29, 2012

 
By:
/s/ Lawrence Helson
  
   
Lawrence Helson
  
   
Chief Executive Officer and Chief Financial Officer
  
 
 
 
 
 

 

SignPath Pharma, Inc. Reports